Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill.
Durham Veterans Affairs Health Care System.
Am J Orthopsychiatry. 2023;93(3):177-187. doi: 10.1037/ort0000661. Epub 2023 Mar 16.
Black Americans are diagnosed with schizophrenia spectrum disorders at more than twice the rate of White individuals and experience significantly worse outcomes following diagnosis. Little research has examined specific factors that may contribute to worse functional outcomes among Black Americans diagnosed with schizophrenia. One approach to understanding why racial disparities emerge is to examine established predictors of functioning in this population: neurocognition, social cognition, and symptom severity. The present study aims to broaden existing literature on racial differences within these domains by (a) examining racial differences in functioning and these established predictors of functioning (i.e., neurocognition, social, and symptom severity) and (b) investigating whether cognition and symptom domains similarly predict functioning between Black and White Americans with schizophrenia. Sixty-six participants' baseline neurocognition, social cognition, symptom severity, and functioning were assessed. Black participants demonstrated lower neurocognition scores and higher levels of disorganized symptoms relative to White participants. No racial differences in functioning or social cognition were observed. Further, race did not moderate the relationship between any of these established predictors and functioning outcomes. The largely nonsignificant differences in known predictors of functioning highlight the need to explore further domains that may be more relevant for understanding racial disparities in schizophrenia. Considering that psychosocial treatments for schizophrenia spectrum disorders often focus on cognition, these results underscore the importance of identifying whether these domains or other treatment targets may be better in addressing racial disparities in functioning. Possible areas of exploration for future work (e.g., structural factors, racism-related stress) are discussed. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
美国黑人被诊断患有精神分裂症谱系障碍的比率是白人的两倍多,并且在诊断后预后明显更差。很少有研究探讨可能导致黑人精神分裂症患者功能结局更差的具体因素。了解为什么会出现种族差异的一种方法是检查该人群中功能的既定预测因素:神经认知、社会认知和症状严重程度。本研究旨在通过(a)检查功能以及这些既定的功能预测因素(即神经认知、社会认知和症状严重程度)方面的种族差异,以及(b)研究认知和症状领域是否同样可以预测黑人和白人精神分裂症患者的功能,来拓宽该领域内关于种族差异的现有文献。评估了 66 名参与者的基线神经认知、社会认知、症状严重程度和功能。与白人参与者相比,黑人参与者的神经认知评分较低,出现紊乱症状的水平较高。在功能或社会认知方面未观察到种族差异。此外,种族并没有调节这些既定预测因素与功能结果之间的关系。功能的已知预测因素差异不大,这突出表明需要进一步探索可能更有助于理解精神分裂症中种族差异的其他领域。鉴于精神分裂症谱系障碍的心理社会治疗通常侧重于认知,因此这些结果强调了确定这些领域或其他治疗目标是否更能解决功能方面的种族差异的重要性。讨论了未来工作的可能探索领域(例如,结构性因素、与种族有关的压力)。